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Abstract
Despite considerable progress in understanding the molecular origins of hereditary human diseases, the molecular basis of
several thousand genetic diseases still remains unknown. High-throughput phenotype studies are underway to
systematically assess the phenotype outcome of targeted mutations in model organisms. Thus, comparing the similarity
between experimentally identified phenotypes and the phenotypes associated with human diseases can be used to suggest
causal genes underlying a disease. In this manuscript, we present a method for disease gene prioritization based on
comparing phenotypes of mouse models with those of human diseases. For this purpose, either human disease phenotypes
are ‘‘translated’’ into a mouse-based representation (using the Mammalian Phenotype Ontology), or mouse phenotypes are
‘‘translated’’ into a human-based representation (using the Human Phenotype Ontology). We apply a measure of semantic
similarity and rank experimentally identified phenotypes in mice with respect to their phenotypic similarity to human
diseases. Our method is evaluated on manually curated and experimentally verified gene–disease associations for human
and for mouse. We evaluate our approach using a Receiver Operating Characteristic (ROC) analysis and obtain an area under
the ROC curve of up to . Furthermore, we are able to confirm previous results that the Vax1 gene is involved in Septo-Optic
Dysplasia and suggest Gdf6 and Marcks as further potential candidates. Our method significantly outperforms previous
phenotype-based approaches of prioritizing gene–disease associations. To enable the adaption of our method to the
analysis of other phenotype data, our software and prioritization results are freely available under a BSD licence at http://
code.google.com/p/phenomeblast/wiki/CAMP. Furthermore, our method has been integrated in PhenomeNET and the
results can be explored using the PhenomeBrowser at http://phenomebrowser.net.
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Introduction
With the advent of whole-genome sequencing, researchers have
focused on understanding the underlying molecular causes of
hereditary human diseases to enable and improve their treatment.
Genetic pleiotropy as well as the polygenic nature of some of the
human genetic disorders create challenges in the quest of
identifying causal genes for a disease. One important tool to
understand human hereditary diseases are animal models. Animal
models of a human disease do not only provide insights into the
pathogenesis of the disease but also enable the evaluation of
therapeutic strategies.
Over the past few years, large-scale mutagenesis projects have
been proposed to systematically identify the phenotypes of
organisms resulting from targeted modifications to the organisms’
genetic markup. Large-scale mutagenesis experiments provide
a thorough examination of species’ phenomes and with that
constitute the tantalizing possibility for revealing valuable in-
formation about the molecular mechanisms underlying human
disease [1]. In particular, phenotype studies in mice have been
demonstrated to provide insights into human disease mechanisms
[2,3].
One outcome of these experiments is the accumulation of large
and rapidly increasing amounts of phenotype data. The bio-
medical community has responded to the challenge of providing
methods for retrieving, analyzing and comparing the data by the
introduction of phenotype ontologies. A large number of
phenotype ontologies is now available for various species, in-
cluding Homo sapiens [4], Mus musculus [5], Caenorhabditis elegans [6],
Drosphila melanogaster [7] and Saccharomyces cerevisiae [8], to provide
standardized and detailed phenotype descriptions within a species.
The challenge we are currently facing is to integrate species-
specific phenotype descriptions across the various species, thereby
enabling the systematic analysis of phenotype information across
species in order to understand the function of genes and their role
in human disease [9].
Two approaches are currently in use to align species-specific
phenotype ontologies. In the first approach, lexical mappings
between the labels and synonyms of concepts in species-specific
phenotype ontologies are used to identify related phenotypes in
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different species [10,11]. The second approach towards integrating
phenotypes across species relies on formal definitions of concepts
in phenotype ontologies using the Phenotype Attribute and Trait
Ontology (PATO) [12] and the Entity-Quality (EQ) syntax [9].
Using the second approach, a phenotype is decomposed into an
affected entity and a quality that specifies how the entity is affected.
The EQ representation allows for the phenotype definitions to be
integrated across species following the application of automated
reasoning over their combination with a cross-species anatomy
ontology [9,13]. This approach has been implemented in the
PhenomeBLAST software and applied to the prioritization of
candidate genes of disease [14].
Several methods have been developed to prioritize candidate
genes for diseases using a variety of data, primarily relying on
known gene–disease associations [15]. For example, the GeneWan-
derer approach [16] employs a distance measure on a protein-
protein interaction network to identify gene–disease associations.
Another system, ENDEAVOUR [17], utilizes a set of known genes
to create profiles which are then used to find matching genes.
SUSPECTS [18] prioritizes genes from a given chromosomal
region, according to available gene and protein information, that
might be implicated in a disease. Since most of the available tools
rely on known gene–disease associations and follow a ‘‘guilt-by-
association’’ approach [15,19,20], they cannot be applied to the
prioritization of genes for diseases with yet unidentified molecular
origins. However, information about phenotypes may be used to
prioritize or predict candidate genes for diseases as well as
functional relations between genes and proteins even in the
absence of knowledge about the molecular basis of a disease [21],
and approaches based on the integration of phenotypes across
species were successfully applied to suggest gene candidates for
diseases [13,14].
Here, we present a method to prioritize candidate genes in mice
based on comparing experimentally derived phenotype data with
phenotype descriptions of human diseases. We apply our method
to the collection of phenotypes available from the Mouse Genome
Informatics (MGI) [22] database and compare those to the disease
phenotypes available from the Online Mendelian Inheritance in
Man (OMIM) database [23]. We evaluate our method using
a Receiver Operating Characteristic (ROC) curve and achieve an
Area Under Curve (AUC) of up to 0:899. Our results demonstrate
that our method significantly outperforms previous phenotype-
based approaches of prioritizing gene–disease associations in-
corporating mouse model data (p~3:2|10{4 and pv1|10{6,
one-tailed Student’s t-test). Furthermore, we are able to provide
evidence that Vax1 (MGI:1277163) is involved in Septo-Optic
Dysplasia (OMIM:#182230) and suggest Gdf6 (MGI:95689) and
Marcks (MGI:96907) as novel candidates. Our software as well as
the data we produced are freely available from http://code.
google.com/p/phenomeblast/wiki/CAMP.
Materials and Methods
Ontology Resources
In our approach, we incorporate the Mammalian Phenotype
Ontology (MP) [5] as well as the Human Phenotype Ontology
(HPO) [4] to analyze and integrate phenotypes. We obtained an
MP version from the OBO Foundry ontology portal [24], last
modified 21 June 2011. The version we downloaded comprised
of 8,658 concepts. Furthermore, we obtained the HPO from
http://www.human-phenotype-ontology.org. The version we
used was last modified on 26 June 2011 and contained 10,282
concepts.
Databases Containing Gene–disease Associations and
Phenotype Information
We used two established resources containing gene–disease
associations: the Mouse Genome Informatics (MGI) database [22]
and the Online Mendelian Inheritance in Man (OMIM) [23]
database. Both databases are populated by curators who manually
extract the relevant information from the literature and report the
information in a consistent framework.
The MGI database integrates genetic, genomic and phenotypic
information about the laboratory mouse [22]. We used three
report files from the MGI database (all accessed on 9 March 2011):
MGI_GenoDisease.rpt, MGI_GenePheno.rpt and HMD_Hu-
man5.rpt. The first report contains associations between diseases
and the genotypes exhibiting the disease phenotype. Moreover,
the report contains all genes that are targeted in the mutant
mouse model that is associated with the disease. The second
report contains the information about genotypes and their
observed phenotypes. The phenotypes are represented using
the MP. The third report file covers the information about
human–mouse orthologous genes.
The OMIM database collects information about human
heritable diseases, including genotype and phenotype information
and known gene–disease associations. The version from 29
November 2010 contained 20,267 entries in total, out of which
13,606 described genes and over 7,000 described diseases [23]. To
incorporate the OMIM information into our study, we obtained
the MorbidMap file on 1 March 2011, available via the database’s
download services. MorbidMap contains the information about
known associations of human diseases and genes. The version we
used, contained 2,717 diseases that were linked to 2,266 genes,
with 3,463 distinct gene–disease associations (on average 1.27
genes per disease). The phenotypes associated with diseases
described in OMIM are available as HPO annotations from the
HPO web site (http://www.human-phenotype-ontology.org). The
downloaded file comprised annotations for 5,027 OMIM entries.
Ontology Mappings
An ontology is a specification of a conceptualization of a domain
[25]. Ontologies consist of a set of concepts and relations as well as
axioms that characterize the intended meaning of the concepts
and relations. A mapping between two ontologies is a set of axioms
that formally inter-relate the concepts and relations belonging to
both ontologies.
We focus on mappings where the axioms relating concepts from
two ontologies take the form of sub- and equivalent-classes axioms
between atomic concepts. In particular, given the two concepts
A[O1 and B[O2, a mapping involving both A and B will be of the
form:
N A SubClassOf: B, or
N B SubClassOf: A, or
N A EquivalentTo: B.
For a concept A[O1, we will say that A maps to the concept
B[O2, if A is either equivalent to B or a subclass of B.
Mappings Through Lexical Matching
One approach to generate mappings between ontologies is to
perform lexical matching on the labels (including synonyms) of
concepts in ontologies [26]. We used the Lexical OWL Ontology
Matcher (LOOM) [10] to generate a set of lexical mappings
between concepts. LOOM generates a match between two
concepts if either the concepts’ labels or synonyms can be
matched lexically with at most a single mismatching character.
Gene Prioritization Based on Phenotype Comparisons
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Using LOOM on the HPO and MP ontologies, we extracted 607
pairs of corresponding HPO and MP concepts.
Due to the use of lexical matching on concept labels, we assume
that the 607 pairs represent equivalent classes axioms. For example,
LOOM generates a match between the HPO concept Melena
(HPO:0002249) and the MP concept melena ( MP:0003292), and
we assume that this match represents the OWL axiom:
HPO:0002249 EquivalentTo: MP:0003292.
For each match generated with LOOM, we added the resulting
equivalent classes axiom to a knowledge base consisting of both
MP and HPO. We then used an automated reasoner to classify the
resulting ontology and with that generate a mapping from HPO to
MP and a mapping from MP to HPO. To extract the mapping
from HPO to MP, we iterated through all concepts in the HPO
and performed a query for all classes that are equivalent to or are
a super-class of the HPO concept and belong to MP. For example,
the HPO concept Progressive childhood hearing loss is mapped to the
MP concepts hearing loss, abnormal hearing physiology, abnormal ear
physiology, hearing/vestibular/ear phenotype and Mammalian Phenotype
based on the lexical match between the HPO concept Hearing loss
(a parent-concept of Progressive childhood hearing loss) and the MP
concept hearing loss. The example is illustrated in Figure 1. The
mappings from MP to HPO were generated equivalently.
Mapping through automated reasoning. Mappings based
on formal definitions were obtained using automated reasoning
over anatomy and phenotype ontologies. For this purpose, we used
the mappings generated by the PhenomeBLAST software for the
PhenomeNET cross-species phenotype network [14] available at
http://phenomeblast.googlecode.com. PhenomeBLAST inte-
grates the formal definitions that were created for concepts from
HPO and MP [9,27], Gene Ontology (GO), UBERON [13],
Mouse Anatomy Ontology [28], Foundational Model of Anatomy
(FMA) [29], Mouse Pathology (MPATH) ontology [30] and
Chemical Entities of Biological Interest (ChEBI) ontology [31] into
a single ontology using a method for combining anatomy and
phenotype ontologies [32]. The ontologies are then converted into
OWL EL to enable efficient automated reasoning [33], and the
CB reasoner is used to classify the resulting ontology [34]. To
generate the mappings from MP to HPO, PhenomeBLAST
identifies all equivalent and super-classes of an MP concept in
HPO, and vice versa for the mappings from HPO to MP.
Combination of mappings. Since both the approaches to
generate mappings between MP and HPO differ substantially, we
combined both approaches and generated a novel mapping based
on the formal definitions for concepts in phenotype ontologies and
the lexical matches between the concepts’ labels and synonyms.
We modified the PhenomeBLAST software to add the additional
equivalent classes axioms derived from the lexical matching to
PhenomeBLAST’s underlying ontology and used the modified
PhenomeBLAST ontology to re-generate mappings between HPO
and MP using automated reasoning. The process of combining
both mapping approaches with each other is illustrated in Figure 2.
As a result, we obtain three different mappings from HPO to
MP, which we call lexical, ontological and merged, and three additional
Figure 1. Illustration of an example mapping based on lexical matching. Concepts on the left side belong to HPO and all the concepts on
the right side belong to MP. Applying LOOM to both ontologies extracted a lexical match between the HPO concept Hearing loss and the MP concept
hearing loss. Based on this lexical match, the HPO concept Hearing loss is declared to be equivalent to the MP concept hearing loss, and the mapping
for HPO’s concept Hearing loss will include the MP concepts hearing loss, abnormal hearing physiology, abnormal ear physiology, hearing/vestibular/ear
phenotype and Mammalian Phenotype. The HPO concept Progressive hearing impairment will be mapped to the same MP concepts as Hearing loss.
Conversely, both the MP concepts hearing loss and deafness are mapped to the HPO concepts Hearing loss, Hearing abnormality, Abnormality of the
ear, Phenotypic abnormality and All.
doi:10.1371/journal.pone.0038937.g001
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mappings (lexical, ontological, merged) from MP to HPO,
resulting in six mappings:
1. two mappings based on lexical matching (from concepts in the
HPO onto concepts in MP and another mapping from
concepts in MP onto concepts in the HPO),
2. two mappings based on automated reasoning over the concept
definitions in phenotype ontologies (from HPO to MP and
from MP to HPO), and
3. two mappings that combine automated reasoning over concept
definitions in phenotype ontologies with lexical matching.
The mappings associate either a concept from MP with a set of
HPO concepts or one HPO concept with a set of MP concepts.
Using the ontological mappings generated through Phenome-
BLAST, concepts from HPO are, on average, associated with 7:1
concepts from MP and MP concepts with 9:3 HPO concepts.
Through lexical matching (using LOOM), HPO concepts are
associated, on average, with 2:3 MP concepts and MP concepts
with 1:0 concepts from HPO. When combining the mappings, the
average number of mapped concepts increases to 7:8 concepts
from MP that are associated with an HPO concept and’ 9:7 HPO
concepts that are associated with an MP concept. Mapping
through lexical matching produces, on average, significantly less
concepts; for 71% of the concepts in HPO, we were unable to
identify any corresponding MP concepts through the lexical
matching approach, and similarly for 86% of the MP concepts, no
corresponding HPO concept could be identified.
To compare the obtained mappings directly with each other, we
determined the overlap of the mappings obtained by either
method given that a mapping for one particular concept was
obtained using either method. Due to non-symmetrical mappings,
we independently assessed both the ‘‘translation’’ directions: HPO
to MP and MP to HPO. While comparing the results, we could
identify four different categories the results fall into: exact overlap
of the mappings, the lexical mappings are a subset of the
ontological mappings, the ontological mappings are a subset of the
lexical mappings, and the lexical and the ontological mapping
overlap for a number of mapped concepts but each possesses also
concepts not contained in the other. The coverage of the obtained
overlap categories is shown in table 1.
Phenotype Similarity between Mouse Models and
Diseases
Based on the ontological mappings between the MP and HPO,
we applied a measure of semantic similarity to compare
experimentally derived phenotype descriptions of mice with the
phenotypes that are associated with human diseases. Figure 3
provides an overview of the experimental setup of our approach.
We used the phenotype annotations of mouse models available
from the MGI database [22] and compared those to the
phenotypes associated with diseases described in OMIM. To
automatically compare the similarity between mouse and disease
phenotypes, we converted either the mouse phenotypes into an
HPO-based representation or the disease phenotypes into an MP-
based representation. This transformation allowed us to perform
Figure 2. Integration of lexical and ontological mapping. The Lexical OWL Ontology Matcher is applied to the Human and Mammalian
Phenotype Ontology to extract lexically matching concepts (based on labels and synonyms). All pairs of lexically matching concepts are inserted as
equivalence class axioms into PhenomeBLAST’s ontology. A mapping is generated by reasoning over PhenomeBLAST’s adapted ontology and
extracting all equivalence and super classes for each concept.
doi:10.1371/journal.pone.0038937.g002
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a similarity-based comparison between phenotypes using either
HPO or MP (also illustrated in Figure 3).
To identify the similarity S(M,D) between a mouse model M
and a disease D, we used the Jaccard index between the
phenotypes P(M) and P(D) that are associated with M and D:
S(M,D)~
DP(M)\P(D)D
DP(M)|P(D)D
P(M) and P(D) are sets of phenotypes that are either expressed
using the MP or the HPO. Both sets are closed with respect to the
taxonomy of either MP or HPO, i.e., if they contain a concept C
from MP or HPO they also contain all of C’s super-concepts. Due
to the inclusion of the ontologies’ structure in the sets of
phenotypes, S(M,D) establishes a measure of semantic similarity
[35,36].
Results
Evaluation of Disease Gene Prioritizations
We computed the phenotype similarity between all mouse
models in the MGI database and all disease phenotypes in OMIM.
First, we utilized the three different mapping approaches (lexical,
ontology-based, and a combination of both) between HPO and
MP to ‘‘translate’’ human disease phenotypes into an MP-based
representation, and compared their semantic similarity with
mouse phenotypes based on MP. Second, we used the three
mapping approaches to ‘‘translate’’ mouse phenotypes into an
HPO-based representation and compared their semantic similarity
with disease phenotypes based on HPO. As a result, we obtain six
distributions of phenotype similarity values for each disease, three
based on HPO’s structure, and another three for the similarity
based on MP.
We individually applied the resulting similarities between mouse
models and diseases to prioritize candidate genes for diseases. For
this purpose, we assume that mouse models with a phenotype that
is similar to a disease phenotype may be a model of that disease
[13,14,21]. To evaluate this assumption, we compared our
prioritization results against known gene–disease associations. To
quantify how well our approach associates diseases with genes that
may cause the disease, we generate and analyze the corresponding
ROC curves. A ROC curve is a plot of the true positive rate as
a function of the false positive rate. The Area Under Curve (AUC)
is a quantitative measure of the performance of a classification task
and is equivalent to the probability that a randomly chosen
positive example is ranked higher than a randomly chosen
negative one [37].
We performed the ROC analysis twice using either a set of
known gene–disease associations in humans (OMIM’s Morbid-
Map) or using a set of gene–disease associations in mice (disease
annotations available in the MGI database). In the absence of
a large set of true negative gene–disease associations, we assume
that only known gene–disease associations constitute positive
Table 1. Illustrates the amount of mappings falling into each
of the overlap categories when both methods are compared.
HPO to MP MP to HPO
# exact 110 93
# lexical 5 ontological 1367 502
# ontological 5 lexical 226 88
# overlap 1316 568
# concepts 3019 1251
Due to the mappings between HPO and MP not being symmetrical, the
mappings are independently compared, once for the HPO to MP ‘‘translation’’
direction and once for the MP to HPO ‘‘translation’’ direction.
doi:10.1371/journal.pone.0038937.t001
Figure 3. Highlights the applied transformation in our method. Our mappings are not symmetrical. Therefore, we can ‘‘translate’’ phenotype
concepts in two directions: we can translate all mouse models into an HPO-based representation (using either the lexical, ontology-based or merged
mapping approach), and we can translate all human diseases into an MP-based representation (using either of the mappings). When both mouse
phenotypes and human diseases are represented using the same ontology, their similarity can be computed to suggest candidate disease genes. The
original data obtained from OMIM (disease annotations in HPO) is illustrated with a brown color whilst the data obtained from MGI is illustrated with
a light blue color. The purple arrows show the ‘‘translation’’ process using either the lexical, the ontological or the combined mapping. Once diseases
and mouse models are represented using the same ontology, the prioritization based on a phenotype similarity will be calculated.
doi:10.1371/journal.pone.0038937.g003
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examples while all unknown associations constitute negative exam-
ples.
As a result, we obtained 12 ROC curves with their associated
AUC values: we performed the similarity-based comparison based
on HPO and based on MP for each of the three mapping
approaches between MP and HPO and vice versa (based only on
lexical matching, based only on reasoning over phenotype
definitions, and based on the combination of both approaches),
and evaluate the results against both MGI’s and MorbidMap’s
gene–disease associations. Figure 4 illustrates the resulting ROC
curves and table 2 shows the AUCs obtained for each.
To determine the impact of the different mapping approaches
on the task of gene prioritization, we determined the correlation
between the prioritization results obtained using the lexical and
the ontology-based mappings. Using Spearman’s rank correlation
coefficient r, the correlation coefficients between the ranks of the
positive examples using the lexical and ontology-based mapping
approaches are 0:703 (HPO-based compared against OMIM’s
gene–disease associations), and 0:813 (MP-based compared
against OMIM’s gene–disease associations), 0:696 (HPO-based
compared against MGI’s gene–disease associations) and 0:741
(MP-based compared against MGI’s gene–disease associations).
Prioritizing Candidate Genes for Orphan Diseases
Based on the results of our quantitative evaluation, we can apply
our method’s prioritization results to suggest candidate genes for
orphan diseases. These can subsequently be studied in more detail
or emphasized in large-scale mutagenesis projects such as the
International Knockout Mouse Consortium [38]. To verify the
potential of our method to correctly prioritize disease gene
candidates, we have manually assessed the prioritization results
obtained when calculating phenotype similarity based on MP and
using the combination of lexical and ontology-based mappings (the
scenario in which we achieved the highest AUC score).
For example, our method predicts knockouts of Gdf6
(MGI:95689), Marcks (MGI:96907) and Vax1 (MGI:1277163) on
ranks 1, 2 and 3 for Septo-Optic Dysplasia (SOD) (OMIM:#182230).
Investigating further, we can suggest that Vax1 could be
a candidate gene for patients suffering from SOD. SOD is
a disorder characterized by any combination of optic nerve
hypoplasia, pituitary gland hypoplasia, and midline abnormalities
of the brain, including absence of the corpus callosum and septum
pellucidum [39]. Vax1 mutations in mice share remarkable
phenotypic similarities with SOD in humans as illustrated in
Figure 5. For example, both the disease and the mouse models are
annotated with abnormal eye development (MP:0001286), abnormal optic
nerve morphology (MP:0001330), and absent corpus callosum
(MP:0002196). Our results confirm a recent study in which Vax1
has been suggested as a strong candidate gene for SOD when no
Hesx1 (MGI:96071) mutations are present [40]. Details on the
steps involved in prioritizing Vax1 for SOD, and parts of the input
data we used (fully provided as supplemental material in
supplementary file S1), are illustrated in Figure 5.
Furthermore, the genes our approach predicts on ranks 1 and 2
for SOD are Gdf6 and Marcks. Gdf6 has previously been identified
to implicate ocular and skeletal abnormalities [41], in particular
abnormalities of the coronal suture between bones in the skull
[42], while deficiency of the Marcks protein in mice has been
shown to result in an absence of the corpus callosum, cortical and
retinal abnormalities [43]. Based on their phenotypic similarity to
SOD (full information also provided as supplemental material in
supplementary file S1), Gdf6 and Marcks are promising novel
candidates for genes involved in SOD.
The HESX1 gene has been identified as a cause of SOD and
hypopituitarism [44,45], and we also identify a Hesx1 model on
rank 22 using our approach.
Discussion
Comparison to Related Work
The majority of the available systems for gene prioritization
follow a ‘‘guilt-by-association’’ approach [15] and use information
about known genes–disease associations to identify genes that are
similar (with respect to a wide variety of features) to known causal
genes for a disease. The features that are used for determining
similarity in these tasks include GO annotations, phenotypes,
information about gene expression, gene regulation, sequence,
homology, interactions and pathway data as well as literature
information [15]. Methods following a ‘‘guilt-by-association’’
approach require prior knowledge about the molecular origins of
a genetic disorder and can not be applied when such information
is not available. An approach based exclusively on comparisons of
phenotypes requires no prior knowledge about molecular
mechanisms underlying a disease and can therefore be applied
to diseases for which the phenotype is known, regardless of
whether genetic causes for the disease are already known.
After pioneering studies have shown that comparisons of
phenotypes can reliably prioritize candidate disease genes [9,13],
two recent approaches, PhenomeNET [14] and MouseFinder
[46], applied phenotype-based gene prioritization in large scale to
data from mouse model experiments.
PhenomeNET implements the first large-scale application of
gene prioritization based on cross-species phenotype similarity
applied to phenotypes of yeast, fly, worm, fish, mouse and human
diseases. Using the whole dataset consisting of phenotypes in six
species, PhenomeNET achieves an AUC in a ROC analysis for
prioritizing gene–disease associations of 0:68 (compared against
a combination of MorbidMap’s and MGI’s gene–disease associa-
tions as positive instances). To compare our results to the
PhenomeNET approach, we restricted the PhenomeNET dataset
to the mouse models and the diseases we used in our approach and
separately evaluated the prioritization results against both,
OMIM’s and MGI’s gene–disease associations. When comparing
against OMIM’s associations, the AUC of PhenomeNET is 0:712,
and when comparing against MGI’s associations the AUC is
0:799.
Our approach (MP-based, using a combination of both lexical
and ontology-based mappings) achieves a significantly improved
performance over PhenomeNET (comparing against OMIM’s
associations: p~3:2|10{4, comparing against MGI’s associa-
tions: pv1|10{6, one-tailed Student’s t-test). The main
difference of our approach to PhenomeNET is the similarity
computation, which we performed using only a single phenotype
ontology (either MP or HPO), while PhenomeNET uses
a combination of five different phenotype ontologies for the
computation of the semantic similarity. The inclusion of multiple,
often redundant (i.e., equivalent) phenotypes classes introduces
additional noise that affects the resulting similarity values.
Furthermore, we utilize lexical mappings in addition to the
ontology-based mappings, while PhenomeNET relied on ontol-
ogy-based mappings exclusively. PhenomeNET also uses
a weighted Jaccard index as a similarity measure while we do
not employ weights. We intend to evaluate the impact of
differences in semantic similarity measures as future research.
Another implementation of using mouse models to prioritize
gene candidates for human genetic disorders is the MouseFinder
[46]. Similar to PhenomeNET, MouseFinder relies on mappings
Gene Prioritization Based on Phenotype Comparisons
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generated via definitions in ontologies and bases the computation
of semantic similarity on a combination of the HPO and MP. In
MouseFinder, several similarity measures are implemented and
the results using either measure are compared, finding that
a similarity measure based on a weighted Jaccard index achieves
the highest recall in the task of gene prioritization. In total, within
the first 500 ranks, MouseFinder reports a recall of 58% when
compared against OMIM’s gene–disease associations and 65%
when compared against MGI’s associations. Since ranks are
shared by multiple mouse models in MouseFinder (i.e., multiple
mouse models with the same similarity values share a rank), we
cannot derive the precision of the MouseFinder approach and
therefore lack the means for a direct comparison.
Cross-species Comparison
The main difference of our method to previous approaches for
phenotype-based gene prioritization is the inclusion of lexical
matches and the use of single, species-specific phenotype
Figure 4. ROC curves resulting from our evaluation. The left panel includes all the results for ‘‘translating’’ mouse models from an MP
representation to an HPO representation and performing the gene prediction in HPO. The right panel includes all the results for a ‘‘translation’’ of
human diseases into an MP-based representation. Each plot shows the evaluation results using each of the three mappings: using lexical matching,
using reasoning over ontologies, and the merged mappings. The two panels on the top are the results of the evaluation against OMIM and the two
panels at the bottom are the results of the evaluation against MGI.
doi:10.1371/journal.pone.0038937.g004
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ontologies to compute phenotypic similarity. We observe signifi-
cant differences in the performance of our method depending on
which mapping method between MP and HPO we apply, which
ontology we use to compute semantic similarity, and against which
set of gene–disease associations we perform our evaluation.
Our first observation is that the performance of our approach is
usually better when using ontology-based mappings than when
using lexical mappings alone. In one case, using MP-based
phenotypic similarity evaluated against OMIM, lexical matching
(AUC 0:732) performs slightly better than ontology-based
matching (AUC 0:727). It seems surprising that the lexical
matching of 607 concepts can almost match ontology-based
mappings (based on more than 10,000 formal concept definitions
in both the MP and HPO) when applied to the task of gene
prioritization. A possible explanation lies in the annotation depth
of mouse models in the MGI database as well as the depth of
concepts that match exactly between the MP and HPO. On
average, mouse models in the MGI are annotated at a depth of 5
in the MP [47]. The concepts that lexically match exactly between
the HPO and MP, however, are mostly specialized, clinical terms
that are used for annotating disease-related phenotypes in OMIM.
These terms denote complex concepts that carry substantial
information about a disorder. As a result of their complexity, they
are often not formally defined and would therefore not map
completely across species when using ontology-based mappings. If
an appropriate MP concept can be identified, all mouse models
that are annotated with it or any of its super-classes will share
features with the clinical term and therefore have some similarity
to the disease that includes the complex clinical phenotype. On the
other hand, mouse models are rarely annotated with these clinical
terms, and mappings through lexical matching may not identify
a single matching class from HPO. While mappings through
lexical matching may prefer one direction (from HPO to MP) due
to the differences in annotation between OMIM and MGI’s
mouse models, we observe no such bias for mappings generated
through automated reasoning over phenotype class definitions.
However, computing similarity within MP performs always
better than computing similarity within the HPO. This may be an
indication that either the structure or the content of the MP is
more suitable for our particular application (i.e., the prioritization
of mouse models) than the structure and content of the HPO. At
the minimum, our method provides an objective, quantitative
measure of the performance of both ontologies and their
definitions with regard to phenotype-based gene prioritization of
Table 2. Areas Under Curve (AUC) measures for all gene
prediction tasks.
based on
mapping HPO MP
lexical ontological merged lexical ontological merged
OMIM 0.678 0.690 0.700 0.732 0.727 0.730
MGI 0.691 0.737 0.748 0.864 0.895 0.899
The results in the first row show the AUC values for comparing against OMIM’s
gene–disease associations, while the results in the second row are the AUC
values when comparing against MGI’s gene–disease associations. Columns
entitled HPO contain the results of the HPO-based gene prediction, whilst
columns entitled MP contain the results of the MP-based gene prediction.
doi:10.1371/journal.pone.0038937.t002
Figure 5. Vax1 is one of the highest ranked mouse model for Septo-Optic Dysplasia. After combining both lexical and ontological mapping
(illustrated in Figure 2), human diseases were ‘‘translated’’ with the combined mapping to an MP representation (results with highest AUC score). We
manually verified some of the MP-based prioritization results (including Septo-Optic Dysplasia). The figure illustrates the original annotation for the
disease based on HPO and its ‘‘translation’’ to MP. It also includes the annotations contained in MGI for mouse models with the Vax1vtm1Grlw
(MGI:1859863) allele. To reduce the complexity of the figure, we did not include all annotations resulting from the ‘‘translation’’ of the disease
annotations and after the enrichment of the mouse model annotations. A full list of all annotations is provided as supplementary material
(supplementary file S1), also including other highly ranked mouse models for Septo-Optic Dysplasia.
doi:10.1371/journal.pone.0038937.g005
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mouse models, and this measure may be used to further develop
and improve the ontologies.
Finally, we observe a significant difference in the performance
of our method depending on whether we evaluate against MGI’s
or OMIM’s gene–disease associations. When evaluating our
predictions against OMIM’s gene–disease associations, we
achieve, at best, an AUC of 0:732 (using lexical mapping, MP-
based similarity computation), while we obtain up to 0:899 when
evaluating against MGI’s gene–disease associations (merged
mapping, MP-based similarity computation). Furthermore, map-
pings through lexical matching perform similar to ontology-based
mapping when evaluating against OMIM, while we observe
a notable decline in performance when evaluating against MGI’s
disease annotations. The magnitude of the difference between
both data sets may be indicative of different guidelines in the
amount of evidence that is required to assert a gene–disease
relation in both databases.
Future Directions for Phenotype Analysis
Our approach is currently limited by the quantity and quality of
cross-species mappings between phenotype ontologies. Possible
further extensions of our approach could be the application of less
restrictive lexical matching algorithms or additional approaches to
ontology mapping [48] to increase the number of matched
concepts. In particular, we currently use exact matching between
phenotype terms to derive lexical mappings between the HPO and
MP. A possible future extension is to incorporate less conservative
matches such as those derived from stemming algorithms.
Furthermore, the mappings could also be improved by in-
vestigating better algorithms to integrate both the lexical and
ontological mapping, allowing, for example, for partial matches
that map to subclass assertions instead of statements of equiva-
lence.
Another future extension is to apply our method to other
resources such as OrphaNet [49] or DECIPHER [50] as well as
other model organism databases. As a first step in this direction,
we have incorporated our results into the PhenomeNET method,
where the results are available via the PhenomeBrowser [14].
Supporting Information
File S1. SOD-supplement.ods The three highest ranked
mouse genes for Septo-Optic Dysplasia are Gdf6, Marcks, and
Vax1. Supporting file S1 contains the original MP annotations of
the three highest ranked mouse alleles corresponding to the
beforementioned genes and also provides the original HPO
annotations for the disease. Furthermore, it also contains the MP
annotations for Septo-Optic Dysplasia after applying the com-
bined lexical and ontological mapping.
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